Your browser doesn't support javascript.
loading
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
Buccisano, Francesco; Palmieri, Raffaele; Piciocchi, Alfonso; Maurillo, Luca; Del Principe, Maria Ilaria; Paterno, Giovangiacinto; Soddu, Stefano; Cerretti, Raffaella; De Angelis, Gottardo; Mariotti, Benedetta; Irno Consalvo, Maria Antonietta; Conti, Consuelo; Fraboni, Daniela; Divona, Mariadomenica; Ottone, Tiziana; Lavorgna, Serena; Panetta, Paola; Voso, Maria Teresa; Arcese, William; Venditti, Adriano.
Afiliación
  • Buccisano F; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Palmieri R; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Piciocchi A; Centro Dati Fondazione GIMEMA, 00100 Rome, Italy.
  • Maurillo L; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Del Principe MI; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Paterno G; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Soddu S; Centro Dati Fondazione GIMEMA, 00100 Rome, Italy.
  • Cerretti R; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • De Angelis G; Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.
  • Mariotti B; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Irno Consalvo MA; Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.
  • Conti C; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Fraboni D; Rome Transplant Network, Tor Vergata University Hospital, 00133 Rome, Italy.
  • Divona M; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Ottone T; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Lavorgna S; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Panetta P; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Voso MT; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Arcese W; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
  • Venditti A; Department of Biomedicine and Prevention, University Tor Vergata of Roma, 00133 Rome, Italy.
Cancers (Basel) ; 13(5)2021 Mar 03.
Article en En | MEDLINE | ID: mdl-33802502
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza